You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high-dose melphalan

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

Completed
Has Results
  • Multiple Myeloma
  • Thalidomide+Melphalan +Bortezomib+stem cell transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Washington, District of Columbia
  • +1 more
May 6, 2022

Multiple Myeloma Trial in Suzhou (Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 3, 2023

Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Newly Diagnosed Patients
  • Torino, Italy
    Division of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)

Completed
  • Multiple Myeloma, Relapsed
  • Multiple Myeloma, Refractory to Standard Treatment
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Nov 20, 2021

Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)

Recruiting
  • Multiple Myeloma
  • Seattle, Washington
    Swedish Cancer Institute
Jun 21, 2022

Multiple Myeloma Trial in Atlanta (BeEAM)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Oct 19, 2022

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

Terminated
Has Results
  • Multiple Myeloma
  • New York, New York
  • +1 more
Oct 3, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Multiple Myeloma Trial in Iowa City (Ascorbate, Melphalan)

Recruiting
  • Multiple Myeloma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Dec 31, 2021

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Neuroblastoma Trial in Minneapolis (drug, biological, radiation)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Amyloidosis Trial in Boston (blood collection, bone marrow collection)

Completed
  • Amyloidosis
  • blood collection
  • bone marrow collection
  • Boston, Massachusetts
    Boston Medical Center
Sep 8, 2021

Amyloidosis Trial in Boston (Bortezomib, Dexamethasone, Melphalan)

Completed
Has Results
  • Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Sep 4, 2020

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Birmingham, London, Southampton (drug, procedure, radiation)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Birmingham, England, United Kingdom
  • +2 more
Dec 18, 2020

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

Myeloma Trial in Houston (Trisenox (Arsenic Trioxide), Velcade (Bortezomib), Melphalan)

Completed
Has Results
  • Myeloma
  • Trisenox (Arsenic Trioxide)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Multiple Myeloma Trial in Germany (Lenalidomide, Dexamethasone, Lenalidomide, Dexamethasone, PBSCT)

Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide, Dexamethasone
  • Lenalidomide, Dexamethasone, PBSCT
  • Muenster, North Rhein Westfallen, Germany
  • +30 more
Feb 9, 2022

Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

Recruiting
  • Multiple Myeloma
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Multiple Myeloma Trial in Nijmegen (Anakinra)

Completed
  • Multiple Myeloma
  • Nijmegen, Netherlands
    Radboud university medical center
Nov 23, 2020